JP2014509860A5 - - Google Patents

Download PDF

Info

Publication number
JP2014509860A5
JP2014509860A5 JP2013558453A JP2013558453A JP2014509860A5 JP 2014509860 A5 JP2014509860 A5 JP 2014509860A5 JP 2013558453 A JP2013558453 A JP 2013558453A JP 2013558453 A JP2013558453 A JP 2013558453A JP 2014509860 A5 JP2014509860 A5 JP 2014509860A5
Authority
JP
Japan
Prior art keywords
antibody
antibody according
seq
amino acid
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013558453A
Other languages
English (en)
Japanese (ja)
Other versions
JP6220675B2 (ja
JP2014509860A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2012/054629 external-priority patent/WO2012123562A1/en
Publication of JP2014509860A publication Critical patent/JP2014509860A/ja
Publication of JP2014509860A5 publication Critical patent/JP2014509860A5/ja
Application granted granted Critical
Publication of JP6220675B2 publication Critical patent/JP6220675B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013558453A 2011-03-16 2012-03-16 診断用抗体アッセイ Expired - Fee Related JP6220675B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161453449P 2011-03-16 2011-03-16
US61/453,449 2011-03-16
PCT/EP2012/054629 WO2012123562A1 (en) 2011-03-16 2012-03-16 Diagnostic antibody assay

Publications (3)

Publication Number Publication Date
JP2014509860A JP2014509860A (ja) 2014-04-24
JP2014509860A5 true JP2014509860A5 (enExample) 2015-04-23
JP6220675B2 JP6220675B2 (ja) 2017-11-01

Family

ID=45833428

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013558453A Expired - Fee Related JP6220675B2 (ja) 2011-03-16 2012-03-16 診断用抗体アッセイ

Country Status (15)

Country Link
US (2) US8809508B2 (enExample)
EP (1) EP2686346B1 (enExample)
JP (1) JP6220675B2 (enExample)
KR (1) KR102020072B1 (enExample)
CN (1) CN103459421B (enExample)
AU (1) AU2012228236B2 (enExample)
BR (1) BR112013023211B1 (enExample)
CA (1) CA2828433C (enExample)
DK (1) DK2686346T3 (enExample)
EA (1) EA032054B1 (enExample)
IL (1) IL227847A0 (enExample)
MX (1) MX343873B (enExample)
SG (1) SG192805A1 (enExample)
WO (1) WO2012123562A1 (enExample)
ZA (1) ZA201305946B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210091830A (ko) 2013-03-15 2021-07-22 비보리온 테라퓨틱스 아게 신규한 억제제
US20170363645A1 (en) 2014-12-19 2017-12-21 Probiodrug Ag Novel Method for the Detection of pGlu-Abeta Peptides
US10494425B2 (en) * 2015-02-24 2019-12-03 Rpeptide, Llc Anti-amyloid-beta antibodies
NZ739181A (en) * 2015-07-16 2023-05-26 Vivoryon Therapeutics N V Anti-pyroglutamated amyloid beta humanized antibodies
GB201910697D0 (en) * 2019-07-26 2019-09-11 Binding Site Group Ltd Lonisation control
CA3151959A1 (en) * 2019-10-01 2021-04-08 James Ronald Peyser Determination of protein concentration in a fluid
KR102790945B1 (ko) * 2022-09-23 2025-04-04 경성대학교 산학협력단 베타-아밀로이드 42를 이용한 치매 진단 방법 및 이를 이용한 치매 진단 키트
CN121253823A (zh) * 2025-10-10 2026-01-02 山东九嘉生物科技有限公司 一种用于检测胃蛋白酶原ⅰ的化学发光试剂盒及其制备方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4737456A (en) 1985-05-09 1988-04-12 Syntex (U.S.A.) Inc. Reducing interference in ligand-receptor binding assays
EP1237930B1 (en) * 1999-12-08 2006-11-08 Intellect Neurosciences, Inc. Chimeric amyloid beta peptides
US7117096B2 (en) * 2001-04-17 2006-10-03 Abmaxis, Inc. Structure-based selection and affinity maturation of antibody library
WO2004013172A2 (en) 2002-07-24 2004-02-12 Innogenetics N.V. Fragments of beta-amyloid as targets for vaccination against alzheimer disease
WO2004029629A1 (en) * 2002-09-27 2004-04-08 Janssen Pharmaceutica N.V. N-11 truncated amyloid-beta nomoclonal antibodies, compositions, methods and uses
WO2005075436A2 (en) 2004-02-05 2005-08-18 Probiodrug Ag Novel inhibitors of glutaminyl cyclase
ES2259270B1 (es) 2005-03-09 2007-11-01 Consejo Superior De Investigaciones Cientificas Metodo de diagnostico in vitro de la enfermedad de alzheimer mediante un anticuerpo monoclonal.
WO2008002893A2 (en) 2006-06-29 2008-01-03 Centocor, Inc. Anti-amyloid antibodies, compositions, methods and uses
ES2468546T3 (es) 2006-11-09 2014-06-16 Probiodrug Ag Nuevos inhibidores de glutaminil ciclasa
JP5599614B2 (ja) 2006-11-09 2014-10-01 プロビオドルグ エージー グルタミニルシクラーゼの新規阻害剤
US8278345B2 (en) 2006-11-09 2012-10-02 Probiodrug Ag Inhibitors of glutaminyl cyclase
ATE554085T1 (de) 2006-11-30 2012-05-15 Probiodrug Ag Neue inhibitoren von glutaminylcyclase
WO2008110523A1 (en) 2007-03-09 2008-09-18 Probiodrug Ag Imidazo [1,5-a] pyridine derivatives as inhibitors of glutaminyl cyclase
ES2468551T3 (es) 2007-04-18 2014-06-16 Probiodrug Ag Derivados de nitrovinil-diamina como inhibidores de la glutaminil ciclasa
JP5675343B2 (ja) 2007-04-18 2015-02-25 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤としての尿素誘導体
WO2008128985A1 (en) 2007-04-18 2008-10-30 Probiodrug Ag Thiourea derivatives as glutaminyl cyclase inhibitors
JP5675341B2 (ja) 2007-04-18 2015-02-25 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤としてのチオキソキナゾリノン誘導体
EP2160380B1 (en) 2007-04-18 2014-04-02 Probiodrug AG Cyano-guanidine derivatives as glutaminyl cyclase inhibitors
JP5676249B2 (ja) 2007-04-20 2015-02-25 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤としてのアミノピリジン誘導体
JP2011500059A (ja) * 2007-10-15 2011-01-06 セントコア・オーソ・バイオテツク・インコーポレーテツド ヒト抗アミロイド抗体、組成物、方法及び使用
AT506820B1 (de) * 2008-06-12 2011-07-15 Affiris Forschungs Und Entwicklungs Gmbh Vakzine gegen alzheimer-krankheit
KR101706789B1 (ko) * 2008-07-21 2017-02-14 프로비오드룩 아게 진단용 항체 검사법
WO2010128139A1 (en) * 2009-05-08 2010-11-11 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin Biomarkers and methods for diagnosing alzheimer's disease and/ or mild cognitive impairment
SI2448968T1 (sl) * 2009-06-29 2021-07-30 Bioarctic Ab Protitelesa, selektivna za protofibrile/oligomere na N-koncu skrajšanega amiloida-beta

Similar Documents

Publication Publication Date Title
JP2011528561A5 (enExample)
KR101982899B1 (ko) TL1a에 대한 항체 및 그의 용도
CA2861793C (en) Method of providing monoclonal auto-antibodies with desired specificity
JP2016516400A5 (enExample)
JP2013506428A5 (enExample)
JP2015535820A5 (enExample)
RS53270B2 (sr) Monoklonalna antitela protiv amiloidnog beta proteina i njihova upotreba
HRP20191342T1 (hr) Anti-phf-tau antitijela i njihove upotrebe
IL212056A0 (en) Monoclonal antibodies and methods for their use in the detection of cervical disease
JP2011511624A5 (enExample)
JP2016020389A5 (enExample)
JP2014518883A5 (enExample)
JP2011173884A5 (enExample)
JP2021500916A5 (enExample)
JP2016531546A5 (enExample)
JP6744857B2 (ja) 生物学的材料およびその用途
JP2013520174A5 (enExample)
JP2013542914A5 (enExample)
JP2013539369A5 (enExample)
WO2014186728A2 (en) Methods for diagnosing and treating inflammatory bowel disease
TR201903026T4 (en) S100A4 ANTIBODIES AND THEIR THERAPEUTIC USES.
WO2014106235A1 (en) Anti-granulysin antibodies and methods of use thereof
RU2017139800A (ru) Комбинированный препарат антител против staphylococcus aureus
RU2014106933A (ru) Способы и композиции для лечения аутоиммунных и воспалительных заболеваний
RU2014133410A (ru) Антитело к blys